MDxHealth SA
MDXH
$3.53
$0.133.82%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 38.86% | 2.94% | -35.45% | 20.61% | -6.72% |
| Total Depreciation and Amortization | -32.96% | 19.47% | -5.37% | 53.35% | -33.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -36.77% | 6.82% | 133.46% | -56.49% | -9.08% |
| Change in Net Operating Assets | 0.57% | -386.89% | 162.37% | 67.43% | -126.64% |
| Cash from Operations | 44.51% | -31.35% | 22.43% | 25.21% | -73.02% |
| Capital Expenditure | 8.57% | 62.90% | -157.27% | 36.78% | -41.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 162.94% | 193.81% | 47.24% | -21.34% | -69.95% |
| Cash from Investing | -1,661.54% | 98.32% | -25.57% | 8.58% | -53.99% |
| Total Debt Issued | 86.97% | -100.58% | -- | -- | -- |
| Total Debt Repaid | 92.73% | 97.04% | -6,125.83% | 45.21% | -7.31% |
| Issuance of Common Stock | -90.50% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -15.99% | -13.81% | -71.17% | 1.50% | 4.30% |
| Cash from Financing | -97.37% | 181.68% | 779.91% | 23.59% | -1.24% |
| Foreign Exchange rate Adjustments | -283.33% | 175.00% | -700.00% | -111.11% | -95.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -108.86% | 307.71% | 186.86% | 23.69% | -52.92% |